Courtney Anne Schreiber, MD, MPH

faculty photo
Stuart and Emily B.H. Mudd Professor in Human Behavior and Reproduction
Attending in Obstetrics and Gynecology, Hospital of the University of Pennsylvania, Department of Obstetrics and Gynecology, Philadelphia, PA
Division Chief, Family Planning, Department of Obstetrics and Gynecology, Penn Medicine
Founder and Director, PEACE, The Pregnancy Early Access Center
Co-Director, Penn Promotes Research on Sex and Gender in Health
Senior Fellow, Leonard Davis Institute of Health Economics (LDI Amplify dissemination training program, 2021)
Human Stem Cell Research Advisory Committee Member, University of Pennsylvania (Office of the Vice Provost)
Chair, Reproductive Health Working Group
Executive Director, FOCUS on Health and Leadership for Women
Lead, Post-Roe Working Group, Penn Medicine
Lead, Elevating Women's Health, OBGYN Strategic Plan, Penn Medicine
Member, Search committee Vice Dean/Vice President of Inclusion, Diversity and Equity, Penn Medicine/PSOM
Penn Medicine BioBank Steering Committee Member, Penn Medicine
Chair, Search Committee Urogynecology Division Chief, PSOM
Department: Obstetrics and Gynecology

Contact information
Department of Obstetrics and Gynecology
3737 Market Street, 12th floor
Philadelphia, PA 19104
Office: 215-615-6531
Fax: 215-615-5319
Education:
B.A. (Religion )
Columbia College, Columbia University, New York NY, 1993.
OTH (Postbaccalaurate Premedical Program)
University of Pennsylvania, Philadelphia, PA, 1995.
M.D.
New York University School of Medicine, New York, NY, 1999.
M.P.H. (Public Health )
University of Pittsburgh, Graduate School of Public Health, Epidemiology Track, Pittsburgh, PA, 2005.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Research Expertise

Clinical Trials
Reproductive Science
Health Policy Research
Reproductive Epidemiology
Contraceptive Technology Development
Sex and Gender Disaggregated Research

Description of Clinical Expertise

Family Planning
Miscarriage
Abortion
Contraception

Description of Other Expertise

Reproductive Health Advocacy and Policy. I have served as an expert witness in over 20 legal cases related to abortion access and reproductive health. My specific areas of contribution include maintaining access to mifepristone and medication abortion.

Selected Publications

Baecher-Lind L, Bird JB, Ginzburg SB, Mann S, Petty EM, Schreiber CA, Gottlieb AS.: State Laws on Reproductive Health and Graduating Medical Students' Choice of Specialty and Residency Location. Acad Med. Page: epub ahead of print. May 2025.

Baecher-Lind L, Bird JB, Ginzburg SB, Mann S, Petty EM, Schreiber CA, Gottlieb AS.: State Laws on Reproductive Health and Graduating Medical Students' Choice of Specialty and Residency Location. Acad Med May 2025.

Abernathy A, Goba M, Forkpa M, Chittams J, Mumford SL, Srinivas SK, Schreiber CA.: Inequitable Screening for Pregnancy Intention by Race, Insurance, and Site of Care in Two High-Volume Urban Obstetric Hospitals. J Womens Health (Larchmt). 34: 469-475, Apr 2025.

Mahoney KM, McKean R, McAllister A, Tannous-Taylor C, Schreiber CA.: Patients' experiences with pain and bleeding in first-trimester abortion care. Am J Obstet Gynecol Feb 2025.

Abernathy A, Goba M, Forkpa M, Chittams J, Mumford SL, Srinivas SK, Schreiber CA.: Inequitable Screening for Pregnancy Intention by Race, Insurance, and Site of Care in Two High-Volume Urban Obstetric Hospitals. J Womens Health (Larchmt) Feb 2025.

Chen J, Nijim S, Koelper N, Flynn AN, Sonalkar S, Schreiber CA, Roe AH.: Telemedicine Follow-up After Medication Management of Early Pregnancy Loss. J Womens Health (Larchmt) Nov 2024.

Chen J, Nijim S, Koelper N, Flynn AN, Sonalkar S, Schreiber CA, Roe AH.: Telemedicine Follow-up After Medication Management of Early Pregnancy Loss. J Womens Health (Larchmt) 33: 1449-1456, Nov 2024.

Edelman A, Jensen JT, Brown J, Thomas M, Archer DF, Schreiber CA, Teal S, Westhoff C, Dart C, Blithe DL.: Emergency contraception for individuals weighing 80 kg or greater: A randomized trial of 30 mg ulipristal acetate and 1.5 mg or 3.0 mg levonorgestrel. Contraception. 137: epub, Sep 2024.

Brown JE, Creinin MD, Wu H, Hubacher D, Schreiber CA, Kaneshiro B, Nanda K, Blithe DL: Menstrual cup use and intrauterine device expulsion in a copper intrauterine device randomized trial. Contraception 134:110415, Jun 2024.

Jensen JT, Edelman A, Westhoff CL, Schreiber CA, Archer DF, Teal S, Thomas M, Brown J, Blithe DL: Use of serum evaluation of contraceptive and ovarian hormones to assess reduced risk of pregnancy among women presenting for emergency contraception in a multicenter clinical trial. Contraception 24:110475, Apr 2024.

back to top
Last updated: 06/23/2025
The Trustees of the University of Pennsylvania